FR2322585A1 - Dispositif de liberation fonctionnant par osmose et son procede de fabrication - Google Patents

Dispositif de liberation fonctionnant par osmose et son procede de fabrication

Info

Publication number
FR2322585A1
FR2322585A1 FR7627006A FR7627006A FR2322585A1 FR 2322585 A1 FR2322585 A1 FR 2322585A1 FR 7627006 A FR7627006 A FR 7627006A FR 7627006 A FR7627006 A FR 7627006A FR 2322585 A1 FR2322585 A1 FR 2322585A1
Authority
FR
France
Prior art keywords
osmosis
manufacturing process
release device
operating release
operating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7627006A
Other languages
English (en)
Other versions
FR2322585B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FR2322585A1 publication Critical patent/FR2322585A1/fr
Application granted granted Critical
Publication of FR2322585B1 publication Critical patent/FR2322585B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A61F6/144—Wirelike structures, e.g. loops, rings, spirals with T-configuration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
FR7627006A 1975-09-08 1976-09-08 Dispositif de liberation fonctionnant par osmose et son procede de fabrication Granted FR2322585A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/611,504 US3977404A (en) 1975-09-08 1975-09-08 Osmotic device having microporous reservoir

Publications (2)

Publication Number Publication Date
FR2322585A1 true FR2322585A1 (fr) 1977-04-01
FR2322585B1 FR2322585B1 (fr) 1980-11-07

Family

ID=24449267

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7627006A Granted FR2322585A1 (fr) 1975-09-08 1976-09-08 Dispositif de liberation fonctionnant par osmose et son procede de fabrication

Country Status (11)

Country Link
US (1) US3977404A (fr)
JP (1) JPS5238015A (fr)
AU (1) AU500192B2 (fr)
CH (1) CH620122A5 (fr)
DE (1) DE2640193C2 (fr)
DK (1) DK144850C (fr)
FR (1) FR2322585A1 (fr)
GB (1) GB1511614A (fr)
IE (1) IE44450B1 (fr)
IT (1) IT1070302B (fr)
SE (1) SE429102B (fr)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016880A (en) * 1976-03-04 1977-04-12 Alza Corporation Osmotically driven active agent dispenser
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4289815A (en) * 1978-06-26 1981-09-15 Airwick Industries, Inc. Cold water-insoluble polyvinyl alcohol pouch for the controlled release of active ingredients
US4340491A (en) * 1978-06-26 1982-07-20 Airwick Industries, Inc. Cold water-insoluble polyvinyl alcohol pouch for the controlled release of active ingredients
US4217898A (en) * 1978-10-23 1980-08-19 Alza Corporation System with microporous reservoir having surface for diffusional delivery of agent
JPS5560459A (en) * 1978-10-26 1980-05-07 Baxter Travenol Lab Polymer that can coexist with blood and medical appliance manufactured from said polymer
US4304232A (en) * 1979-03-14 1981-12-08 Alza Corporation Unit system having multiplicity of means for dispensing useful agent
US4439194A (en) * 1981-09-08 1984-03-27 Merck & Co., Inc. Water and drug delivery system for suppository use
IE54171B1 (en) * 1982-06-22 1989-07-05 Univ Glasgow Device for introducing nutrients and/or therapeutic materials into ruminant animals
DE3378159D1 (en) * 1982-08-24 1988-11-10 Nat Res Dev Fluoride-containing compositions
US5310559A (en) * 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
US5468501A (en) * 1982-09-01 1995-11-21 Hercon Laboratories Corporation Article useful for administration of pharmacologically-active substances transdermally, orally or by means of implant
AT396056B (de) * 1983-03-04 1993-05-25 Alza Corp Verfahren zur herstellung einer vorrichtung zur kontinuierlichen abgabe eines wirkstoffes, insbesondere eines arzneimittels an eine waesserige verwendungsumgebung
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
US4618487A (en) * 1984-07-06 1986-10-21 Alza Corporation Device for administering calcium ascorbate
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
DE3786199T2 (de) * 1986-04-03 1993-09-23 Hercon Lab Artikel fuer die verabreichung pharmakologisch aktiver substanzen.
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
FR2651643B1 (fr) * 1989-09-11 1993-06-18 Rhone Poulenc Sante Systeme de liberation continue de la vitamine a dans l'eau d'alimentation.
DK0542926T3 (da) * 1990-08-07 1995-05-15 Pfizer Brug af grænsefladepolymeriserede membraner i frigivelsesanordninger
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US20080045573A1 (en) * 1993-09-20 2008-02-21 Bova David J Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US5458887A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
US5725493A (en) * 1994-12-12 1998-03-10 Avery; Robert Logan Intravitreal medicine delivery
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
DE59804823D1 (de) 1997-09-25 2002-08-22 Bayer Ag Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
US20040121014A1 (en) * 1999-03-22 2004-06-24 Control Delivery Systems, Inc. Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6616652B1 (en) 2000-02-15 2003-09-09 Microsolutions, Inc. Osmotic pump delivery system with pre-hydrated membrane(s) and/or primable catheter
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
US6471688B1 (en) 2000-02-15 2002-10-29 Microsolutions, Inc. Osmotic pump drug delivery systems and methods
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
ATE455526T1 (de) * 2000-08-24 2010-02-15 Sidney Lerner Nicht-hormonales vaginales verhütungsmittel
US6632217B2 (en) * 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
EP2316394B1 (fr) 2001-06-12 2016-11-23 The Johns Hopkins University Dispositif à réservoir pour administration intraoculaire de médicaments
EP1414416A4 (fr) * 2001-07-10 2007-06-27 Teva Pharma Systeme d'administration de medicament permettant l'administration de medicament d'ordre zero, biphasique d'ordre zero, ascendante ou descendante
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US20070184104A1 (en) * 2001-10-25 2007-08-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
CN1620284B (zh) * 2001-12-24 2010-04-28 特瓦制药工业有限公司 含有用粉末或粒状材料的压缩环状体包鞘的有效成分片芯的剂型,及其生产工艺和工具
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
CA2484874A1 (fr) * 2002-05-06 2003-11-13 Ranbaxy Laboratories Limited Systeme monocompartiment d'administration de medicament a regulation osmotique
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
FR2855761B1 (fr) * 2003-06-03 2006-02-24 Optis France Sa Dispositif oculaire de delivrance variable de principes actifs par iontophorese
WO2005004837A1 (fr) * 2003-07-10 2005-01-20 Galen (Chemicals) Limited Dispositifs d'administration de medicaments par voie intravaginale
WO2005044468A1 (fr) * 2003-10-29 2005-05-19 Akzo Nobel N.V. Procede et appareil de dosage d'un medicament ou autre substance visqueuse
EP2532683A3 (fr) 2003-11-28 2013-03-20 Eastman Chemical Company Interpolymères de cellulose et procédé d'oxydation
WO2005060946A1 (fr) * 2003-12-17 2005-07-07 Pfizer Products Inc. Polytherapie continue avec des agonistes selectifs des recepteurs ep4 de la prostaglandine et un oestrogene pour le traitement de pathologies se manifestant par une faible masse osseuse
DE102004023069A1 (de) 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
US8246569B1 (en) 2004-08-17 2012-08-21 California Institute Of Technology Implantable intraocular pressure drain
CN101132800A (zh) * 2004-11-24 2008-02-27 席拉坎有限责任公司 一种用于眼内药物释出的植入体
US8252331B2 (en) * 2004-12-03 2012-08-28 Osmotica Kereskedelmi és Szolgáltató, KFT Osmotic device containing amantadine and an osmotic salt
US8574626B2 (en) 2004-12-03 2013-11-05 Osmotica Kereskedelmi és Szolgáltató KFT Osmotic device containing amantadine and an osmotic salt
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
EP1690540A1 (fr) * 2005-02-15 2006-08-16 Neuro3D Composition comprenant l'ocapéridone
US20060258994A1 (en) * 2005-05-12 2006-11-16 Avery Robert L Implantable delivery device for administering pharmacological agents to an internal portion of a body
US20090176882A1 (en) * 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
CA2833354C (fr) * 2006-03-14 2015-12-15 University Of Southern California Dispositif mems et procede de livraison d'agents therapeutiques
US9308124B2 (en) * 2007-12-20 2016-04-12 University Of Southern California Apparatus and methods for delivering therapeutic agents
MX2010007382A (es) 2008-01-03 2010-12-20 Univ Southern California Dispositivos implantables para suministro de farmacos, y aparato y metodos para recargar los dispositivos.
US9849238B2 (en) 2008-05-08 2017-12-26 Minipumps, Llc Drug-delivery pump with intelligent control
MX2010012213A (es) * 2008-05-08 2011-05-03 Minipumps Llc Bombas implantables y cánulas para las mismas.
JP2011519695A (ja) 2008-05-08 2011-07-14 リプレニッシュ パンプス， エルエルシー 植設可能な薬物送達デバイスおよびそのデバイスを充填する装置および方法
US8231609B2 (en) 2008-05-08 2012-07-31 Minipumps, Llc Drug-delivery pumps and methods of manufacture
US20100151020A1 (en) * 2008-12-16 2010-06-17 Vered Rosenberger Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate
EP2391419B1 (fr) 2009-01-29 2019-06-12 ForSight Vision4, Inc. Administration d'un médicament dans le segment postérieur
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
JP5758388B2 (ja) 2009-08-18 2015-08-05 ミニパンプス， エルエルシー 適応制御を有する電解質薬物送達ポンプ
JP2013515741A (ja) * 2009-12-23 2013-05-09 サイヴィーダ ユーエス，インコーポレイテッド 持続放出性送達デバイス
PT2600812T (pt) 2010-08-05 2021-11-09 Forsight Vision4 Inc Aparelho para tratar um olho
JP6111194B2 (ja) 2010-08-05 2017-04-05 フォーサイト・ビジョン フォー・インコーポレーテッド 組み合わせ薬物送達方法および装置
AU2011285545B2 (en) 2010-08-05 2014-03-13 Forsight Vision4, Inc. Injector apparatus and method for drug delivery
EP2640360A2 (fr) 2010-11-19 2013-09-25 Forsight Vision4, Inc. Formulations d'agents thérapeutiques pour des dispositifs implantés
US9603997B2 (en) 2011-03-14 2017-03-28 Minipumps, Llc Implantable drug pumps and refill devices therefor
US10286146B2 (en) 2011-03-14 2019-05-14 Minipumps, Llc Implantable drug pumps and refill devices therefor
US9919099B2 (en) 2011-03-14 2018-03-20 Minipumps, Llc Implantable drug pumps and refill devices therefor
EP4249059A3 (fr) 2011-06-28 2023-11-29 ForSight Vision4, Inc. Un appareil pour collecter un échantillon de fluide à partir d'une chambre réservoir d'un dispositif thérapeutique pour l'oeil
EP2739252A4 (fr) 2011-08-05 2015-08-12 Forsight Vision4 Inc Administration de petites molécules à l'aide d'un dispositif thérapeutique implantable
HUE054578T2 (hu) 2011-09-16 2021-09-28 Forsight Vision4 Inc Fluidumcserélõ berendezés
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10010448B2 (en) 2012-02-03 2018-07-03 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014152959A1 (fr) 2013-03-14 2014-09-25 Forsight Vision4, Inc. Systèmes pour l'administration intra-oculaire entretenue de composés à faible solubilité provenant d'un implant de système de pose d'orifice
EP2978393B1 (fr) 2013-03-28 2023-12-27 ForSight Vision4, Inc. Implant ophtalmique pour administrer des substances thérapeutiques
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
WO2016011191A1 (fr) 2014-07-15 2016-01-21 Forsight Vision4, Inc. Dispositif et méthode de pose d'implant oculaire
EP3177289A4 (fr) 2014-08-08 2018-03-21 Forsight Vision4, Inc. Formulations stables et solubles d'inhibiteurs de la tyrosine kinase de récepteurs, et procédés de préparation de ces dernières
SG11201703726XA (en) 2014-11-10 2017-06-29 Forsight Vision4 Inc Expandable drug delivery devices and method of use
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN108430405B (zh) 2015-11-20 2021-04-13 弗赛特影像4股份有限公司 用于缓释药物递送装置的多孔结构
EP3435977A4 (fr) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. Composition pharmaceutique d'hormone stéroïde
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017176886A1 (fr) 2016-04-05 2017-10-12 Forsight Vision4, Inc. Dispositifs implantables d'administration de médicaments par voie oculaire
WO2019103906A1 (fr) 2017-11-21 2019-05-31 Forsight Vision4, Inc. Appareil d'échange de fluide pour système d'administration à port extensible et méthodes d'utilisation
US10213393B1 (en) 2018-02-15 2019-02-26 Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság Composition and method for treating neurological disease
US10213394B1 (en) 2018-02-15 2019-02-26 Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság Composition and method for treating neurological disease
US20190247331A1 (en) 2018-02-15 2019-08-15 Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság Composition and method for treating neurological disease
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3760804A (en) * 1971-01-13 1973-09-25 Alza Corp Improved osmotic dispenser employing magnesium sulphate and magnesium chloride
US3878977A (en) * 1972-03-02 1975-04-22 American Can Co Flexible container with arcuate self-sealable spout
US3765414A (en) * 1972-03-10 1973-10-16 Hydro Med Sciences Inc Drug release system
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3851648A (en) * 1973-10-11 1974-12-03 Mead Johnson & Co Zero-order release device

Also Published As

Publication number Publication date
GB1511614A (en) 1978-05-24
JPS618042B2 (fr) 1986-03-11
AU1718076A (en) 1978-03-02
DK144850C (da) 1982-11-15
JPS5238015A (en) 1977-03-24
IT1070302B (it) 1985-03-29
IE44450L (en) 1977-03-08
IE44450B1 (en) 1981-12-02
DK144850B (da) 1982-06-21
CH620122A5 (fr) 1980-11-14
DE2640193A1 (de) 1977-03-24
US3977404A (en) 1976-08-31
SE429102B (sv) 1983-08-15
DE2640193C2 (de) 1986-04-10
SE7609404L (sv) 1977-03-09
DK402476A (da) 1977-03-09
FR2322585B1 (fr) 1980-11-07
AU500192B2 (en) 1979-05-10

Similar Documents

Publication Publication Date Title
FR2322585A1 (fr) Dispositif de liberation fonctionnant par osmose et son procede de fabrication
BE842511A (fr) Dispositif semi-conducteur et son procede de fabrication
FR2309036A1 (fr) Dispositif semiconducteur et son procede de fabrication
FR2301186A1 (fr) Article adsorbant et son procede de fabrication
BE838886A (fr) Article absorbant et son procede de fabrication
FR2321756A1 (fr) Dispositif solenoide
FR2307281A1 (fr) Procede et dispositif pour la fabrication technique de porte-objets prerevetus
BE841041A (fr) Procede et dispositif de regrigeration
FR2298776A1 (fr) Procede et dispositif
FR2301850A1 (fr) Procede et dispositif pou
FR2325194A1 (fr) Dispositif de pompage de charge pour semi-conducteur et son procede de fabrication
BE849775A (fr) Dispositif de revetement etanche, notamment pour terrasses, et son procede de fabrication
FR2334205A1 (fr) Dispositif semi-conducteur et son procede de fabrication
BE842182A (fr) Lucknomycine et son procede de preparation
FR2316747A1 (fr) Dispositif photo-emetteur a etat solide et son procede de fabrication
FR2334880A1 (fr) Dispositif de debrayage
SE7608905L (sv) Anordning for behandling av foremal
BE846873A (fr) Lentille a surface non spherique et son procede de realisation,
FR2304299A1 (fr) Chaussure perfectionnee et dispositif de fabrication
CH511635A (fr) Procédé et dispositif de fabrication de monocristaux
FR2309025A1 (fr) Condensateur enroule et son procede de realisation
BE844391A (fr) Polytriazines et leur procede de fabrication
FR2301073A1 (fr) Procede et
FR2330408A1 (fr) Agent antihemophilique et son procede de preparation
BE825212A (fr) Procede et dispositif de degagement et de deploiement de cables de filaments

Legal Events

Date Code Title Description
ST Notification of lapse